Camparison Effects of Autologous Conditioned Serum, platelet rich plasma and Prolotherapy in treatment of Knee osteoarthritis

Phase 3

• Conditions: Knee osteoartritis.; Osteoarthritis of knee

• Registration Number: IRCT20100720004422N6
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Age between 40-75
Grade I-II-III of OA (Kellgren-Lawrence)
Pain severity >4 in a 10-numbered linear scale
Pain in more than 3 months

Exclusion Criteria

Grade IV of OA
Multifactorial Knee Pain
Lower limb Deformity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Functional condition. Timepoint: At the beginning of the study(before the intervention) ? one and six months after treatment. Method of measurement: Western Ontario and McMaster (WOMAC) questionair.;Pain severity. Timepoint: Visual Analogue Scale (VAS) and Western Ontario and McMaster (WOMAC) questionnaire. Method of measurement: At the beginning of the study(before the intervention) and one and six months after treatment.